BIM
NVIV

BlackRock Investment Management’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

BlackRock Investment Management’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$535K Hold
7
– – ﹤0.01% 3030
2016
Q3 		$878K Hold
7
– – ﹤0.01% 2758
2016
Q2 		$747K Hold
7
– – ﹤0.01% 2833
2016
Q1 		$856K Buy
7
+2
+40% +$215K ﹤0.01% 2590
2015
Q4 		$682K Hold
5
– – ﹤0.01% 2848
2015
Q3 		$815K Hold
5
– – ﹤0.01% 2749
2015
Q2 		$1.52M Buy
+5
New +$1.32M ﹤0.01% 2452

Other funds holding NVIV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Investment Management's NVIV Position: Q4 2016 in Review

BlackRock Investment Management held its InVivo Therapeutics Holdings Corp (NVIV) position steady in Q4 2016 at 7 shares worth $535K. The position accounts for ﹤0.01% of the portfolio, ranked #3030.

BlackRock Investment Management first reported a position in NVIV in Q2 2015 and has held it in 7 quarters since. The position peaked at $1.52M in Q2 2015. 51 funds tracked by Wall St. Rank hold NVIV as of Q4 2016.

  • BlackRock Investment Management held 7 shares of InVivo Therapeutics Holdings Corp worth $535K as of Q4 2016.
  • BlackRock Investment Management left its InVivo Therapeutics Holdings Corp share count unchanged in Q4 2016.
  • InVivo Therapeutics Holdings Corp made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3030 holding.
  • BlackRock Investment Management first reported a position in InVivo Therapeutics Holdings Corp in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Investment Management's InVivo Therapeutics Holdings Corp position peaked at $1.52M in Q2 2015.
  • 51 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.